期刊
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
卷 9, 期 4, 页码 1510-1515出版社
ELSEVIER
DOI: 10.1016/j.jaip.2020.10.022
关键词
Epidemic thunderstorm asthma; Grass pollen; Allergens; Allergic rhinitis; Sensitization; Allergen-specific IgE; Melbourne; Risk factors; Biomarkers; Asthma treatment
Identifying characteristics of at-risk individuals can help clinical professionals develop suitable and personalized treatment plans to prevent future loss of life.
Epidemic thunderstorm asthma (ETSA) is a global health problem that can strike without sufficient warning and can have catastrophic consequences. Because of climate change, future events are likely to become more common, more disastrous, and more unpredictable. To prevent loss of life and avoid surge events on health care infrastructure, identifying at-risk individuals and their potential biomarkers is the most prophylactic approach that can be taken to mitigate the deadly consequences of ETSA. In this review, we provide an update on the clinical mechanism, global prevalence, and characteristics of those patients moderately or severely at risk of ETSA. Identifying these patient characteristics will aid clinical professionals to provide suitable and personalized treatment plans and, in turn, avoid future loss of life. (C) 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据